TuHURA Biosciences
HURA
5 hedge funds and large institutions have $97K invested in TuHURA Biosciences in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
29% less funds holding
Funds holding: 7 → 5 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
85% less capital invested
Capital invested by funds: $667K → $97K (-$570K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$10.8K |
| 2 |
Jane Street
New York
|
+$10.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$551K |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$7K |
HURA Hedge Fund Activity: Q3 2018 in Review
5 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q3 2018, worth a combined $97K — down 85% from $667K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of HURA and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Citadel Advisors, adding an estimated $10.8K. The largest seller was Franklin Resources, exiting entirely with an estimated $551K sold.
- 5 institutional investors held TuHURA Biosciences (HURA) as of Q3 2018, down from 7 in Q2 2018.
- Funds reported $97K of TuHURA Biosciences stock for Q3 2018, down 85% quarter-over-quarter.
- 1 fund opened new TuHURA Biosciences positions in Q3 2018 and 3 closed out, a net change of -2 holders.
- The largest TuHURA Biosciences buyer in Q3 2018 was Citadel Advisors, an estimated $10.8K added.
- The largest TuHURA Biosciences seller in Q3 2018 was Franklin Resources, an estimated $551K sold.
Based on aggregated 13F filings for Q3 2018.